AKT1 and neoplasm: OLFML2B may activate a number of cancer-associated pathways, such as PI3K-Akt signaling pathway, focal adhesion, ECM–receptor interaction, proteoglycans in cancer, and leukocyte transendothelial migration, which indicates that OLFML2B may promote tumorigenesis, migration, and regulate tumor immune response.